Replies to post #26408 on Greater Cannabis Company Inc (GCAN)

[Sprycel]

FANTASTIC NEWS!!!! IT JUST GETS BETTER EACH DAY!

Symtomax are at the forefront to offer cheaper production, providing products at the certification grade Europe requires. With current demand outstripping supply in the European Union, it’s easy to see why Symtomax are confident about how they have positioned themselves. Symtomax’s vision and strategic direction is evident in the recently announced partnership. In May of this year Symtomax and Greater Cannabis Company a publicly traded biopharmaceutical, based out of Baltimore, with a focus on the development and commercialisation of cannabinoid delivery systems, signed a joint agreement giving rights to use their tested patented delivery products & distribution throughout Europe, Middle East and Africa.

With concern growing over vaping and the numerous incidents now being reported, Symtomax’s new oral patch, provides a safe alternative delivery platform that can be utilised to deliver cannabinoids directly into the body without the harmful side effects of smoking or vaping, and with quicker onset and greater bioavailability than ingestibles.

[No-Quarter]

Excellent find Gman!

[resx18]

AITAN ZACHARIN CEO & Director $GCAN
• Experienced executive with broad
knowledge in managing and operating
public and private CPG, biotech, and
consumer technology companies
• Founded Fuse Science, a public
biotech company with novel
encapsulation technology and
consumer products business, achieved
a $110M market cap, successfully
commercialized three brands
throughout a 15,000 door footprint,
and activated high profile brand
ambassadors to endorse the products,
and drive purchasing

[Cameo Brien]

This was very helpful

[dollar dude]

Show me the sells. Oh ya there are (NONE)